Fractional Flow Reserve Market by Technology {Invasive Monitoring (Pressure Guidewires and FFR Measurement System) and Non-invasive monitoring}, Application (Single-vessel Diseases and Multi-vessels Diseases): Global Market Size Estimates and Forecast (2022-2030)

The market crossed the US$ 696.41 million mark in 2022 and is expected to hit US$ 2,585.43 million by 2030, recording a CAGR of 15.8% during the forecast period.

The fraction flow reserve market has been significantly growing with cardiac procedures among individuals.

The Invasive Monitoring Segment Held the Largest Market Share of the Fractional Flow Reserve Market in 2022.

Based on technology, the fractional flow reserve market is bifurcated into invasive and non-invasive monitoring. The invasive monitoring segment accounted for the largest market share in the year 2022 and will remain the same during the forecasted year. The growth of this segment is attributed due to the technology use and monitoring system and pressure guidewire for the measurement of fractional flow reserve.

Within the report, the market is segmented into technology, application, and geography. By technology, the market is bifurcated into Invasive monitoring and Non-Invasive monitoring. On the basis of technology, the market is further sub-segmented into Pressure guidewire and FFR measurement systems. By technology, the market is segmented into single-vessel diseases and multi-vessel diseases. Geographically, the market is sub-segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

The Increasing Geriatric Population and Rising CVD Prevalence is the Major Factor in Accelerating Market Growth.

The growth of the market is driven due to increase in the geriatric population across the globe. According to the UN World Population Ageing Report 2022, the global geriatric population (aged 60 years and above) is expected to reach 8.5 billion by 2030 and 9.7 billion in 2050.

Elderly-aged people are highly susceptible to cardiovascular disorders and other chronic disorders, and the high demand for advanced diagnostic and treatment options is expected to increase in the coming years. Torpid lifestyle, smoking, hypertension, high blood cholesterol levels, physical inactivity, high BMI, and high blood sugar levels are the leading risk factors for heart disease and stroke. With the rising prevalence of CVD, the number of related diagnostic and treatment procedures is expected to increase significantly across the globe in the coming years.

Growth Potential in Developing Economies Empowers the Market Growth of the Future

Emerging economies like India, Brazil, and China are anticipated to provide wide potential growth opportunities for players who are in the fractional flow reserve market. Currently, more than half of the world’s population lives in countries like India and China, and these countries are home to a large patient base. Speedy economic growth and increasing per capita incomes in developing markets assist patients in these countries to spend on quality healthcare services, thereby helping players in the fractional flow reserve market to expand their presence in these emerging markets.

Recent Strategic Developments in the Fractional Flow Reserve Market.

The fractional flow reserve market has undergone several significant developments, and a few of these have been mentioned below:

• In July 2021, HeartFlow proclaimed it is merging with Longview acquisition corp. II, to become a publicly traded corporation. Upon accomplishment of the proposed transaction, the combined corporation will operate as HeartFlow Group Inc.
• In March 2019, the US FDA approved Abbott's Resting Full-cycle Ratio (RFR) intravascular diagnostic test, a new type of fractional flow reserve (FFR)
• In January 2019, Opsens received CE mark certification for its diastolic pressure algorithm (“dPR”) Proprietary Resting Index.
• In March 2018, HeartFlow Inc. entered into a collaborative research agreement with the Imperial College London to work on joint projects in the areas of medical imaging and deep learning.

The fractional flow reserve market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. Abbott, Boston Scientific, ACIST Medical Systems, Koninklijke Philips N.V., Opsens, Inc., HeartFlow, Inc., Siemens Healthineers, Pie Medical Imaging, CathWorks, and Medis Medical Imaging Systems BV (Netherlands) are among the prominent players operating in the market.

The target audience for the report:

• Raw material providers
• Government bodies, such as regulating authorities and policymakers
• Venture capitalists, private equity firms, and start-up companies
• Central Laboratory, Hospitals and Clincs
• End users of devices
• Research institutes, organizations, and consulting companies

Scope of the report:

In this report, the market has been segmented on the basis of:

• Technology:

• Invasive Monitoring
  • Pressure Guidewires
  • FFR Measurement Systems
• Non-invasive Monitoring

• Application:

• Single-vessel Diseases
• Multi-vessel Diseases

• Region:

• North America
• Europe
• Asia Pacific
• South & Central America
• Middle East & Africa

• Companies profiled:

• Abbott
• Boston Scientific
• ACIST Medical Systems
• Koninklijke Philips N.V.
• Opsens, Inc.
• HeartFlow, Inc.
• Siemens Healthineers
• Pie Medical Imaging
• CathWorks
• Others

The List of Companies:
- Abbott
- Boston Scientific
- ACIST Medical Systems
- Koninklijke Philips N.V.
- Opsens, Inc.
- HeartFlow, Inc.
- Siemens Healthineers
- Pie Medical Imaging
- CathWorks
- Others